Background. Lithium, a drug frequently used for treatment of affective disorders, is known to cause a vasopressin resistant state, leading to polyuria and polydipsia. It has been suggested that lithium interacts with the renal V 2 -vasopressin receptor. Detailed studies on the influence of lithium on the AVP receptor, however, have so far been difficult due to the lack of a suitable radioligand with high specific activity and high affinity. Methods. Using
I-[8-(p-(OH)-phenylpropionyl)]-
LVP, we studied the effects of lithium on V 2 -vasopressin receptors in male Sprague-Dawley rats and LLCPKj cells. Rats, having free access to water, were orally treated with 10 mg lithium/100 mg b.w./day or placebo for 10 days. Scatchard analysis was performed using membranes prepared from homogenized renal papillae. Results. Lithium caused significant polyuria and an impaired renal concentration capacity after water deprivation. Binding studies showed no effect of lithium on binding affinity K D (0.98 + 0.21 nmol/1 vs. 0.86 + 0.15 nmol/1 (Li) (n.s.). Receptor density, however, significantly decreased from 130 + 12.3 nmol/kg protein in controls (« = 8) to 101.7+ 13.4 nmol/kg protein (n = 8), (P<0.05). Plasma osmolality and AVP were not significantly altered by lithium treatment. Vasopressin receptor density on LLC-PK^-cells, a pig renal cell line, was not changed by preincubation with lithium (312 ±22 nmol/kg vs. 329 + 25 nmol/kg (Li) (w = 6, n.s.). Conclusions. The decrease of AVP-receptor density in vivo might be related to vasopressin resistance, either primary, or secondary to other factors, e.g. actual water transport.
Key words: lithium; vasopressin; polyuria; vasopressin receptor; vasopressin resistance AVP-receptors [1] [2] [3] . In the complete absence of vasopressin, the clinical syndrome of diabetes insipidus develops, characterized by a maximally diluted urine and an inability to conserve water [4, 5] . Defects in the primary structure of vasopressin receptors lead to the syndrome of congenital nephrogenic diabetes insipidus [6] . Much more frequently, however, is the acquired form of ADH resistance [5] . By virtue of its widespread use in the treatment of affective disorders, lithium has emerged as perhaps the most common cause of acquired nephrogenic diabetes insipidus [7, 8] . The mechanism by which lithium opposes the antidiuretic effect of AVP is not clear, however [9] . Recently, Marples et al. [10] have demonstrated an effect of lithium in the collecting duct of the rat to decrease the density of apical water channels (aquaporin-2), possibly explaining at least some of the lithium-induced nephrogenic diabetes insipidus [10] . This however, does not exclude a role of vasopressin receptors. A direct effect of lithium on the renal V 2 -receptor has only recently addressed by binding studies [11] . These studies, however, have been hampered by the lack of a radioligand with high specific activity and high affinity for the renal V 2 -AVP-receptor. We have recently developed such a radioligand and proven its usefulness in examination of small amounts of biological material [12] [13] [14] . In the present study, we examined the effect of oral lithium administration on V 2 -AVP-receptors of plasma membranes from rat renal papillary collecting ducts ex vitro. In addition, to control for any possible direct effects of lithium on the vasopressin receptor, we tested the effects of lithium on AVP receptors of LLC-PKj cells, a renal cell line known for its high vasopressin receptor density.
Methods

Introduction
It is well established that vasopressin (AVP) acts on the collecting tubule through cAMP-generating V 2 -ad libitum. One group of 24 animals was treated orally for 10 days with 10 mg of lithium/100 g b.w. daily (given as 1% lithium carbonate solution twice daily by gastric tube) for a period of 10 days, 24 controls received the same volume in the form of vehicle fluid. The lithium dose used in these experiments has been shown in earlier experiments to lead to lithium concentrations of 0.44 + 0.03 mmol/1 in plasma [9, 15] . This dose has also not been shown to lead to morphological changes, as judged by light or electron microscopy [9, 15] . After decapitation at day 10, blood was collected in ammonium-heparinized tubes for measurements of AVP plasma concentration and of plasma osmolality. Kidneys were rapidly removed and papillae were prepared as described before.
A water deprivation test was performed in 15 male Sprague-Dawley rats (8 lithium treated rats, 7 placebotreated rats). After 10 days of treatment with lithium or placebo, a water deprivation test was performed for 36 h. Urine volume and urine osmolality were measured every 12 h. with high affinity to V,-and V,-AVP-receptors comparable to AVP, was prepared and used as described previously [12] . In brief, prior to conjugation, the free a-amino group of LVP (Bachem) was blocked by incubation in 68% acetone for 48 h. 10 ng acetone-LVP was then reacted with 1 mCi of [ 125 I]-[8-(p(OH)-phenylpropionyl-N-hydoxysuccinimidyl ester in 20 ul N,./v~-dimethylformamide (DMF) and triethylamine (TEA) (1:100 v/v). Conjugation was allowed to proceed for 4 h at room temperature. The conjugated label, diluted in 150 ul of 0.1% trifluoroacetic acid (TFA), was then purified by C-18 reverse-phase high pressure liquid chromatography (HPLC). The isopropylidene moiety protecting the a-amino group was removed by heating the peptide for 30 min in 1 ml 0.2 M acetic acid in a boiling water bath before the second HPLC purification. The fractions with AVP-like immunoreactivity in the second HPLC run were stored at 4°C in 2 ml ethanol-water-acetic acid (80:20:4). Due to the large difference in the retention times between the a-amino protected and deprotected peptide specific activity of the iodinated tracer approached the theoretically maximal value (~2000 Ci/mmol). In the presence of bacitracin, binding of the radioligands to a membrane preparation of LLC-PK, cells or rat renal papillary membranes was rapid, saturable, and reversible [17] .
Materials
Preparation of plasma membranes of rat renal papillae Binding studies
Kidneys were removed and the renal papilla was placed in Tris buffer at 4°C (100 mM Tris-Cl, 0.5 mM EDTA, 1 g/1 bacitracin, pH 7.8, 21°C). Tissue was homogenized with a mechanical Ultra Turrax® (Jahnke & Kunkel, Staufen, Germany) and a potter homogenisator at highest speed of rotation. The homogenate was centrifuged for 5 min at lOOg (4°C). Supernatant was again centrifuged for 20 min in a Sorvall® centrifuge at 3000 g (4°C). The pellet was resuspended in a binding Tris-HCl buffer (100 mM Tris-Cl, 5mM MgCl 2 , pH 7.8, 21°C).
Cell culture and membrane preparation
LLC-PK, cells (ATCC CRL 1392, 181. passage) were grown and cultured as described previously [14] . In order to study the effect of preincubation with lithium, cells were grown for the last 2 days before harvesting with and without 2 mmol/1 lithium chloride. Cells were then detached from the culture dish by incubation for 15 min with 0.1% sodium EDTA, 0.15 M NaCl and 50 mM Tris-Cl, pH 7.4. Plasma cell membranes from LLC-PK, cells were prepared by resuspension in hypotonic Tris-Cl buffer (5 mM, pH 7.4) containing 3 mM MgCl 2 , and 1 mM Na 2 EDTA, followed by homogenization using 10 strokes in a tightly fitting Potter-Elvehjam homogenizer and two subsequent centrifugations in a high speed Eppendorf microcentrifuge after resuspending in hypotonic Tris buffer.
Protein determination
Protein concentration was determined using the Bio-Rad* protein kit with IgG as standard [16] . Colour reaction was measured at 578 nm in an Eppendorf photometer.
Renal papillary membranes.
For one binding study the papillae of 3 rats were pooled. Binding experiments were carried out as cold saturation studies, as described previously [12] . We have demonstrated previously that 125 I-[8-(p-(OH)-phenylpropionyl)]-LVP and AVP have identical affinities for the AVP-V 2 -receptor in saturation studies [12] . Increasing amounts of unlabeled arginine vasopressin (0 to 510~8mol/l) and a constant concentration of radiolabeled vasopressin (60000 cpm/tube) were used. This tracer concentration corresponds to 20 fmol per tube at a specific activity of 2000 Ci/mmol and a counting efficiency of 78%. Nonspecific binding was assessed in the presence of excess AVP (10~6-10"~5 M). Incubation was performed for 90 min at room temperature in a binding buffer with the following components: 100 mM Tris-Cl, 5 mM MgCl 2 , 0.1% BSA, 0.1% bacitracin, pH 7.8. The incubation assay (150 |il) contained 50 ul papillary membrane homogenisate (containing at least 20 |ig of papillary membrane protein per tube), 50 ul standard and 50 ul radioligand. Incubation was terminated by adding 750 ul iced buffer (lOOmM Tris-Cl, 10 mM MgCl 2 , pH7.8, 21°C). After centrifugation at 39000g (14 min, 4°C) the supernatant was removed and the procedure was repeated. The pellet was counted for 10 min in a gamma scintillation counter (Packard). LLC-PKi plasma cell membranes. Binding experiments with membranes of LLC-PK,-cells (>20ug protein/tube) were carried out as described previously [12] . In brief, increasing amounts of unlabeled LVP (0 to 5-10~8 mol/1) and a constant concentration of radiolabeled VP (60000 cpm/tube) were used. Nonspecific binding was assessed in the presence of excess LVP (10" 6 -10~5 M). The binding assay conditions were otherwise identical to the method described above. Vasopressin radioimmunoassay. Radioimmunoassay of vasopressin was performed by a method described by Morton el al. [18] , as described previously [19] . In brief, heparinized J. Hensen et al. blood samples were centrifugated for 20 min at 3000 r.p.m. (4°C). AVP was extracted from plasma using CIS-reversephase-cartridges (Sep-pak®, Water Associates, Milford, Mass. USA). After elution with methanol extracts were dried and dissolved in 150 ul buffer (0.005 M Tris-HCl, pH 7.5, 0.525% human serum albumin, 0.35% neomycin sulfate). AVP-standard was from the WHO Institute London (320pg/ml). The assay contained 50 ul AVP-extract or -standard, 50 ul antibody and 50 ul tracer (0.5 pg/50 ul). Incubation period was 72 h at 4°C. The incubation was terminated by addition of 1 ml of 1% iced dextran-coatedcharcoal-suspension followed by centrifugation at 1600 g for 10 min. The supernatant containing bound AVP was counted for 20 min in a gamma scintillation counter. Plotting of the standard curve and calculation of the results were accomplished with the help of a computer program (spline function). Plasma osmolality was measured by freezing point depression using an automatic digital osmometer (Roebling MeCtechnik, Berlin). Statistics. Scatchard plots were computed by 'Ligand' [20] . Results were statistically analysed with Mann-Whitney U test. Data are given as mean + SEM.
Results
Mean baseline 24-h urinary volume in 24 lithium treated rats (Li rats) and 24 control rats was 10.7 + 0.6 and 12.4 + 0.9 ml, respectively. Baseline water intake was 22.6+1.8 ml and 24.6 + 2.0 ml, respectively. Water intake and urinary volume significantly increased during treatment with lithium (Table 1) , reaching a 24-h urinary volume of 43.2+ 3.2 ml on day 10 of lithium treatment in that group of animals.
In six out of 48 rats, determination of plasma osmolality and AVP was not possible because insufficient material was obtained for determination. Plasma osmolality 10 days after treatment was 304.7 + 3.14mosm/kginLirats(«=15)and303.0±2.3 mosm/kg in controls (« = 21) (n.s.) ( Table 2) . Plasma AVP after treatment with lithium (1.47 + 0.35; « = 15) tended to be higher than in the control group (1.25 + 0.31; n = 2l; n.s.) ( Table 1) . Inclusion of four lithium-treated rats and two control rats with extremely high AVP-levels (»2 SD higher than mean) also did not lead to significant differences between both groups. Table 1 . Water intake, urinary volume, plasma AVP and plasma osmolality after 10 days of treatment with lithium (n = 24) or placebo (n = 24) As high AVP-levels could not be related to an elevated plasma osmolality in these rats, stress induced AVPsecretion was regarded as the most probable cause of the high AVP-concentration in these animals.
The results of the water deprivation test is given in Table 2 . After water deprivation for 36 h maximal urine osmolality in Li rats was significantly lower than in the control group (1415 + 127 mosmol/kg vs. 1817 + 6 mosm/kg, /*<0.05). Urinary volume during the last 12 h of water deprivation was significantly higher after Li (5.3 + 0.5 ml versus 3.1 +0.5 ml, P<0.05).
Binding of
I-8(p[OH]-phenylpropionyl)-LVP to papillary ADH-receptors of rat papillary membranes
was specific and saturable, as reported previously [21] . Mean total bound and nonspecific binding averaged 9% of total counts, and 35% of total bound, respectively. Treatment with lithium significantly decreased density of AVP-receptors (Table 3) . Receptor density (#MAX) was 101.7+ 13.4 nmol/kg protein in the lithium Receptor density on LLC-PK^-cells was 312 + 22 nmol/kg protein without lithium. Preincubation with Li did not change receptor density significantly (329 + 25 nmol/kg protein, n = 6, n.s.). KD was 0.58 ±0.1 nmol/1 and 0.54 + 0.1 nmol/1, respectively (n.s.).
Discussion
The present results confirm the findings by numerous authors (for review see [8, [22] [23] [24] that lithium induces polyuria, polydipsia and an impairment in renal concentration capacity.
The mechanism that leads to polyuria after lithium is not clear. Animal studies have demonstrated an effect of lithium to stimulate thirst very early in the course of lithium administration [25] , but this dipsogenic effect is not evident after more prolonged administration [26] . In some reported patients polyuria was also-in part-attributable to lithium induced polydipsia [27] .
The suggestion that lithium impairs vasopressin secretion from the pituitary [28] is not supported by the finding of several authors [26, 29, 30] . Lithium probably causes reciprocal changes in the secretion and action of vasopressin by diminishing the renal sensitivity to AVP, while increasing the sensitivity of the vasopressin secretory response to osmotic stimulation [27, 29] . In our study, plasma vasopressin and plasma osmolality were not significantly increased after lithium. There was a tendency towards a higher plasma osmolality and plasma vasopressin after lithium, however, the relation between vasopressin and lithium in 625 the present study was not significantly changed. In summary, our data do not confirm an altered relationship between vasopressin and plasma osmolality after lithium.
With respect to the kidney, convincing evidence has been presented in the literature showing a lithium induced nephrogenic diabetes insipidus [31, 32] . This is also in accordance with the findings of the present study. Thus, when lithium rats in our study were subjected to a water deprivation test, maximal urinary concentration was found to be impaired. Under these circumstances any possible lithium induced thirst was without importance, because of the water deprivation.
In addition, our measurements demonstrated comparable plasma AVP-levels in lithium treated rats and controls after 10 days of treatment. We have not measured plasma AVP at the end of the water deprivation; however, it is known that plasma AVP is increased under these conditions [29] . Thus, it is very likely that the impairment of maximal urinary concentration occurred in the presence of ample vasopressin, which is characteristic of nephrogenic diabetes insipidus.
Urinary concentration is primarily dependent on at least submaximal stimulation of renal collecting duct principal cell vasopressin receptors and subsequent maximal 'insertion' of aquaporin-2 water channels into the luminal cell membrane. In a recent study in the rat, using antibodies to aquaporin-2, Marples et al. [10] were able to demonstrate that lithium induced a dramatic reduction by approximately 66%, in the density of collecting duct apical aquaporin-2 channels. Although this study did not attempt to directly test the consequences of such a reduction on hydraulic permeability of the collecting duct, it is now highly likely that some of the lithium-induced nephrogenic diabetes insipidus will be accounted for by the reduction in water channels that can be inserted in response to AVP in the presence of lithium.
It has been suspected previously that lithium impairs cellular cAMP generation after stimulation by the appropriate hormone. In fact this is suggested to be the mechanism of lithium induced hypothyroidism [33] . Whether a similar mechanism applies to the kidney-and how it might come about-has not clearly been established. Detailed studies could demonstrate that lithium decreases vasopressin, but not cAMPstimulated water flow in the toad bladder, thus suggesting a defect in vasopressin induced cAMP generation [34] . Several studies have subsequently been able to confirm the defect in the vasopressin receptor adenylate cyclase cascade [35, 36] . In this respect, the present study sought to determine whether AVP receptor density might be involved. This has been difficult to study in the past, because the available vasopressin analogues for studying renal V 2 -AVP receptors either have a low affinity and high specific activity or vice versa [11] . This was overcome in our study by using a recently developed radioligand with high affinity and high specific activity [12] . We observed that renal papillary vasopressin receptor density was significantly reduced after lithium treatment. The renal papilla contains primarily collecting duct cells, although it also contains interstitial cells, vasa rectae (capillary) tissue, and thin ascending and descending limbs of Henle. It is well known that the majority of renal papillary vasopressin receptors are V 2 -vasopressin-receptors from collecting ducts, and only few V r vasopressin receptors are present. Taken together our study suggests that V 2 -vasopressin receptors are reduced on basolateral membranes of renal papillary collecting duct cells. Similar changes might occur on cortical collecting tubules as well. Although we did not measure cAMP generation in such tissue it is possible that it might be reduced to a comparable extent as was the density of AVP receptors and that this then might contribute to the lithium induced nephrogenic diabetes insipidus. The opposite, i.e. an concomitant increase in AVP receptor density and cAMP production was recently demonstrated after chlorpropamide treatment [21] .
An imbalance between V r and V 2 -vasopressin receptors might, however, also be of some importance. For instance, prostaglandins, stimulated by the V,-vasopressin-receptor action of AVP, are well known to reduce the V 2 -induced production of cAMP in collecting duct cells and thus their AVP-dependent increase in water permeability [37, 38] . Rather than just a diminishment in the number of AVP receptors, an imbalance between both receptor subtypes could also be involved in the lithium induced concentrating defect. It would thus be interesting to study the binding of both V r and V 2 -vasopressin receptor ligands in the same membrane preparation.
The mechanism (s) behind these changes remain to be determined. For instance, it is conceivable that lithium causes interstitial changes in the papilla which are then associated with alterations of receptor density. This may be tested in future studies. However, our present experiments suggest that a direct influence of lithium per se on the vasopressin receptor might be unlikely, since our observations on LLC-PK r cells are negative. Indeed, this negative finding in LLC-PK r cells is not in accordance with the working hypothesis. A possible explanation for this divergence is that LLCPKpcells are derived from pig proximal tubule cells and possess a somehow different vasopressin receptor [39] . Unfortunately there are basically no other renal cell lines showing a high density of vasopressin receptors than LLC-PKj-cells. A promising model to study might be V 2 -AVP-receptors of isolated renal collecting tubules. Another explanation for our divergence is that the conditions of urinary concentration themselves are necessary to bring about the receptor changes observed under lithium. For example, the reduction in apical to basolateral water-flow, induced by a severely reduced density of apical water channels as discussed recently [10] might be related to a correspondingly reduced V 2 -vasopressin receptor-density. In other words on the basis of published works by others [10] in conjunction with the present observation, collecting duct principal cells might be subject to 'cross-talk' or a negative feedback between apical and basolateral events, with respect to water transport. Since it appears possible to J. Hensen et al. manipulate aquaporin-2 water channels by techniques of molecular biology, and since related changes may not only induce nephrogenic diabetes insipidus but also the opposite-i.e. hyponatremia-this hypothesis appears to be one which should be tested in studies in the near future.
